Literature DB >> 12072763

Giant-cell tumor of the appendicular skeleton.

Michelle A Ghert1, Marco Rizzo, John M Harrelson, Sean P Scully.   

Abstract

The common objective of all surgical procedures in the treatment of giant-cell tumor of bone is to minimize the incidence of local recurrence. The purpose of this study was to determine what, if any, patient factors, tumor characteristics, or surgical practices correlate with local recurrence. Seventy-five patients treated for a giant-cell tumor of the appendicular skeleton were followed up for at least 2 years. The mean duration of followup was 62 months (range, 24-224 months). The highest proportion of patients had intralesional curettage, high-speed burring, and adjuvant treatment. Ten patients (13%) had a local recurrence. Bivariate analysis revealed that, with the numbers available, none of the patient variables, tumor variables, or surgical approaches correlated with local recurrence. Post hoc power analysis revealed the power of the study to be 33% to detect a clinically significant difference between treatment groups. The data presented here potentially could contribute to a metaanalysis, which would have the statistical power to determine which tumor-related factors and surgical techniques are most important in predicting recurrence in giant-cell tumor of bone.

Entities:  

Mesh:

Year:  2002        PMID: 12072763     DOI: 10.1097/00003086-200207000-00025

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  36 in total

1.  Which treatment is the best for giant cell tumors of the distal radius? A meta-analysis.

Authors:  Yu-Peng Liu; Kang-Hua Li; Bu-Hua Sun
Journal:  Clin Orthop Relat Res       Date:  2012-07-07       Impact factor: 4.176

2.  Recurrence in giant cell tumour of bone: imaging features and risk factors.

Authors:  Cheng-Sheng Wang; Jiang-Hua Lou; Jin-Sheng Liao; Xiao-Yi Ding; Lian-Jun Du; Yong Lu; Ling Yan; Ke-Min Chen
Journal:  Radiol Med       Date:  2012-08-08       Impact factor: 3.469

3.  Similar local control between phenol- and ethanol-treated giant cell tumors of bone.

Authors:  Wei-Hsin Lin; Tsung-Yu Lan; Chih-Yu Chen; Karl Wu; Rong-Sen Yang
Journal:  Clin Orthop Relat Res       Date:  2011-07-06       Impact factor: 4.176

4.  Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy.

Authors:  F Malek; P Krueger; Z N Hatmi; A A Malayeri; H Faezipour; R J O'Donnell
Journal:  Int Orthop       Date:  2006-08-02       Impact factor: 3.075

Review 5.  Prognosis of local recurrence in giant cell tumour of bone: what can we do?

Authors:  Yifeng He; Ji Zhang; Xiaoyi Ding
Journal:  Radiol Med       Date:  2017-03-07       Impact factor: 3.469

6.  A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.

Authors:  Yifeng He; Jun Wang; Ji Zhang; Fei Yuan; Xiaoyi Ding
Journal:  Radiol Med       Date:  2017-03-07       Impact factor: 3.469

7.  Ethanol as a local adjuvant for giant cell tumor of bone.

Authors:  Kevin B Jones; Barry R DeYoung; Jose A Morcuende; Joseph A Buckwalter
Journal:  Iowa Orthop J       Date:  2006

8.  Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.

Authors:  Richard D Lackman; Eileen A Crawford; Joseph J King; Christian M Ogilvie
Journal:  Clin Orthop Relat Res       Date:  2008-11-06       Impact factor: 4.176

9.  Management of juxta articular giant cell tumors around the knee by custom mega prosthetic arthroplasty.

Authors:  Mayil Vahanan Natarajan; R Prabhakar; Sameer M Mohamed; Ra Shashidhar
Journal:  Indian J Orthop       Date:  2007-04       Impact factor: 1.251

10.  High-Speed Burring with and without the Use of Surgical Adjuvants in the Intralesional Management of Giant Cell Tumor of Bone: A Systematic Review and Meta-Analysis.

Authors:  H Algawahmed; Robert Turcotte; F Farrokhyar; M Ghert
Journal:  Sarcoma       Date:  2010-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.